September 2020

Column

Editor's Page

Aligning Technologies With the Goals of Precision Medicine

09/18/2020

Winston Wong, PharmD, Editor-in-Chief

Advances in information and communication technology are constantly improving and streamlining how health care is being delivered, as well as how providers are interacting and interfacing with their patients. Health...

...

09/18/2020

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model

09/18/2020

Maureen Hennessey, PhD, CPCC, CPHQ

Larry Blandford, PharmD—Column Editor

The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...

The...

09/18/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Population Health Partnerships to Advance Value-Based Care

09/18/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

The business model for health care in the United States is evolving from a volume-driven model to a consumer-centric, value-driven model. As such, there are new competencies required of hospitals and health systems...

The...

09/18/2020

Journal of Clinical Pathways

Department

Research in Review

09/18/2020

JCP Editors

Improved Patient-Reported Outcomes With Palliative Radiation Therapy for Multiple Myeloma The use of palliative radiation therapy among patients with MM is associated with 5 times lower total symptom scores compared...

...

09/18/2020

Journal of Clinical Pathways

Conference Preview

Pathways as a Tool to Improve the Patient Journey and Advance Alternative Payment Models

09/18/2020

JCP Editors

The health care sector is undergoing a shift in the way care is delivered, in the way outcomes are measured, and in how services are reimbursed. The movement has been toward more data-driven science with an emphasis...

The...

09/18/2020

Journal of Clinical Pathways

Feature

From the Field

Developing Pathway to Cure: A Multimodal Clinical Pathway Platform to Support Timely and Appropriate Care of Women Under 50 Diagnosed With Breast Cancer

09/18/2020

Robin M Lally, PhD, MS, RN, AOCN, FAAN1,2

Roksana Zak, PhD1

Ryan Ramaekers, MD3

Allison F Coates, BS, BSN, RN1

Elizabeth Reed, MD2

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Perspectives

Primary Care Increasingly on the Front Lines of Clinical Genetics: Standard Practice and Data Concerns

09/18/2020

Joel Diamond, MD, FAAFP

Abstract: Many health care leaders find themselves in an unexpected situation as market awareness around precision medicine grows: primary care providers increasingly have become the front line for genetic and...

...

09/18/2020

Journal of Clinical Pathways

Current Issue

April 2024

Volume 10

Issue 2

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

Biliary Tract Cancers (BTCs) Unveiled: Expert Perspectives on Unique Challenges and Management Considerations

11/20/2023

In this supplement, learn about the complexities of biliary tract cancer (BTC) with insights from a distinguished expert panel. The supplement examines the patient journey to diagnosis and treatment of BTCs, evaluates the impact of the...

In this supplement, learn about...

11/20/2023

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Twitter

Editorial Correspondence

September 2020

Column

Department

Feature

Current Issue

Special Reports

Subscribe

Twitter

Volume 6

Specialties

Events

Year Round Education

HMP Global Products